Menopause News

Fezolinetant 45 mg once daily was statistically significantly more effective in reducing moderate to severe vasomotor symptom frequency compared with other nonhormonal — but not hormone-based — therapies in the U.S., researchers reported.

Statin therapy could lower the odds of blood clot formation conferred by hormone therapy in perimenopausal women, according to a case-control study published in JAMA Network Open.

Perceived stress and certain gastrointestinal factors were linked to menopausal symptoms, with reproductive stages, physical activity, BMI and previously diagnosed depression or anxiety affecting symptom severity, researchers reported.

Women with metabolic syndrome are more likely to have increased risk for atherosclerotic changes than women without metabolic syndrome, regardless of whether they also have obesity, according to study findings published in Menopause.

An oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids was associated with some improved menopausal symptoms short term compared with estrogen plus progestogen therapy, researchers reported in Menopause.

Among menopausal women, therapeutic touch and music therapy were associated with improved sleep quality, quality of life, and somatic, psychological and urogenital symptoms of menopause after 4 weeks, researchers reported.

Stressful life experiences, such as adverse childhood experiences, were not associated with age at natural menopause despite a negative impact of stress on the health of midlife women, researchers reported in Menopause.

DENVER — Therapeutic lifestyle modifications, particularly focusing on diet quality, can improve long-term cardiometabolic health for perimenopausal and postmenopausal women, according to a presenter at the Lifestyle Medicine Conference.

Current menopause smartphone apps require more information on osteoporosis, expert input and better quality, functionality and simplicity of use and understanding for the general public, researchers reported.

Postmenopausal women who stopped or never used hormone therapy over a 5-year period experienced a loss in bone density, whereas bone density was maintained for those who continued treatment, researchers reported in Menopause.